Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials

Jeffrey O. Urieto, TieFu Liu, Jennifer H. Black, Kimberley A. Cohen, Philip D. Hall, Mark C. Willingham, Lewis K. Pennell, Donna E. Hogge, Robert J. Kreitman, Arthur E. Frankel

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences